Latest News in Pharma industry13 hours agoBoehringer Ingelheim's Schizophrenia Drug Trials Fail to Deliver, Shaking Up the Mental Health Treatment Landscape1 day agoScilex Expands Global Rights for Game-Changing Gout Treatment Gloperba®, Targets Booming $2B Market1 day agoOmeros Narsoplimab Breakthrough Drug Slashing Mortality in TA-TMA Patients Heads for FDA Approval2 days agoGilead Boosts Biotech Stake with 19.4% Ownership in HOOKIPA Pharma Amid Merger Talks4 days agoRevolutionizing Genetic Engineering: mvGPT Unveiled as a Game-Changing All-in-One Gene Therapy Tool4 days agoIncyte’s Ambitious 2025 Vision: Breakthrough Launches and Trials Amid Pipeline Challenges and Patent Expiry Pressures5 days agoJohnson & Johnson Eyes $14 Billion Deal to Acquire Biotech Star Intra-Cellular Therapies5 days agoRevolutionizing Healthcare: HHS Unveils Game-Changing AI Strategic Plan for Innovation, Equity, and Growth in 20256 days agoGilead Sciences and LEO Pharma Strike $1.7 Billion Deal to Revolutionize Anti-Inflammatory Treatments7 days agoEli Lilly Poised for $2.5 Billion Scorpion Therapeutics Acquisition to Revolutionize Cancer Treatment7 days agoFDA to Review Brexpiprazole-Sertraline Combo for PTSD: A Potential Game-Changer in Mental Health Treatment7 days agoHMNC Brain Health Breaks Ground with Largest Precision Psychiatry Trial for Depression: Promising Hope for Personalized Mental Health Treatment7 days agoVerdiva Bio Shatters Records with $411M Series A to Revolutionize Obesity Treatment Market7 days agoIGM Biosciences Faces Major Crisis: Autoimmune Therapies Scrapped, Workforce Slashed, Stock Crashes 70%7 days agoCity Therapeutics and Bausch + Lomb Unite to Revolutionize Vision Care with Groundbreaking RNAi Therapy for Geographic Atrophy8 days agoIGM Biosciences Halts Key Programs, Slashes Workforce by 73% in Major Strategic Shakeup8 days agoFDA Grants Fast Track Status to BridgeBio’s Groundbreaking Lung Cancer Therapy, BBO-85209 days agoGSK Poised for $1 Billion Breakthrough Deal to Acquire Biotech Innovator IDRx9 days agoMaaT Pharma's Breakthrough Phase 3 Trial Results for MaaT013: A Game-Changer in GI-aGvHD Treatment9 days agoJohnson & Johnson's MARIPOSA Trial Revolutionizes NSCLC Treatment with Breakthrough Combo Therapy, Outperforming Current Standards9 days agoAMD's $20M Bet on AI Drug Discovery: Transforming Healthcare with Absci Partnership9 days agoVir Biotechnology Unveils Groundbreaking Cancer Therapy Results, Stock Soars 42% in Pre-Market Rally10 days agoPharmaEssentia's Breakthrough Trial Results Position P1101 as a Game-Changer in Essential Thrombocythemia Treatment10 days agoInari Medical's Stock Soars 30% on Stryker's $4.9 Billion Acquisition Deal11 days agoHeart Failure Market Set to Skyrocket to $40.5 Billion by 2032: Unmet Needs and Breakthrough Therapies Fuel Growth11 days agoAmgen’s IMDYLLTRA® Gains UK Conditional Approval: A Breakthrough in Treating Aggressive Lung Cancer14 days agoBreakthrough in Bladder Cancer: HMBD-001 Shows Remarkable Results in Early Trials15 days agoZepbound Achieves 20.2% Weight Loss, Surpassing Wegovy's 13.7%: A Game-Changer in Obesity Treatment17 days agoAltamira Therapeutics' Circular RNA Breakthrough: Investment Insights and Market Potential of the CycloPhore™ Platform19 days agoCEL-SCI's $5M Public Offering Targets Development of Promising Cancer Therapy Multikine21 days agoAlphamab Oncology’s JSKN033: A Breakthrough in Cancer Therapy with Innovative Dual-Action Approach21 days agoFDA Approves TEVIMBRA: A Game-Changer in Gastric Cancer Treatment by BeiGene24 days agoAstraZeneca Faces Class Action Lawsuit: Allegations of Fraud and Executive Detention Shake Global Pharma Giant24 days agoBruker Hit with $31.6M Damages and U.S. Sales Ban on GeoMx Products Amid Legal Showdown with 10x Genomics25 days agoFDA Grants Priority Review to Nuvation Bio’s Taletrectinib: A New Hope for Advanced Lung Cancer Treatment27 days agoAI Revolutionizes Drug Discovery: Breakthroughs, Challenges, and the Future of Pharmaceutical Innovation28 days agoPfizer's Win: FDA Approves First-Line BRAFTOVI® Therapy for Aggressive Colorectal Cancer28 days agoGuardant Health and MiBA Join Forces to Revolutionize Cancer Care with AI-Driven Precision Medicine29 days agoZealand Pharma Faces FDA Setback on Glepaglutide, Charts Bold Path for Global Approval29 days agoTNF Pharmaceuticals Launches Comprehensive Trial to Combat Muscle Loss in GLP-1 Weight Loss Drug Users30 days agoUCB Shifts Focus After Parkinson’s Drug Trial Failure: A New Hope with Glovadalen30 days agoMerck Strikes $2 Billion Deal with Hansoh for Game-Changing Oral Obesity Drug32 days agoGSK’s Jemperli Receives EMA’s Green Light for Expanded Approval in Endometrial Cancer, Paving the Way for Life-Saving Treatment32 days agoPureTech's Breakthrough Drug Deupirfenidone Sets New Benchmark in IPF Treatment with Groundbreaking Phase IIb Results34 days agoNovo Nordisk’s $16.5 Billion Deal to Supercharge Weight-Loss Drug Production Amid Global Demand Surge35 days agoUK's Landmark Clinical Trials Overhaul Poised to Revolutionize Healthcare and Drive Pharma Innovation37 days agoCandel Therapeutics’ CAN-2409 Achieves Breakthrough in Prostate Cancer Treatment with Groundbreaking Phase III Results38 days agoNew Amsterdam Pharma’s Obicetrapib Triumphs in Phase III BROADWAY Trial, Stock Soars 35%39 days agoLantern Pharma's LP-300 Shines in Phase II Lung Cancer Trial: Breakthrough for Never-Smokers in Asia40 days agoDefense Bill Showdown: Biosecure Act Dropped Amid Controversy, Gender-Affirming Care Restrictions Spark DebateLoad More
